1 Table of Contents
1.1 List of Figures
1.2 List of Tables
2 Key Findings, 2018
2.1 Snapshot
2.2 Overview of Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Trials

3 Clinical Trials Trends to 2022
3.1 Ongoing Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Trials by Phase
3.2 Ongoing Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Trials by Type
3.3 Ongoing Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Trials by Recruitment Status

4 Country Level Analysis
4.1 Region wise Ongoing Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Trials
4.2 Top 10 Countries conducting Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Trials
4.3 Trials in Emerging and Developing Economies

5 Company Level Analysis
5.1 Ongoing Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Trials by Sponsor Type
5.2 Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 Enrolment Trends to 2022
6.1 Subjects Recruited for Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Trials by year
6.2 Subjects Recruited for Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Trials by Phase
6.3 Subjects Recruited for Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Trials by Trial Type
6.4 Subjects Recruited for Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Trials by Recruitment Status

7 Ongoing Trials- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company Details
7.1 Ongoing Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Trials- Phase 1
7.2 Ongoing Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Trials- Phase 2
7.3 Ongoing Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Trials- Phase 3
7.4 Ongoing Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Trials- Phase 4

8 Appendix
8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology
Figure 1: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Clinical Trials by Country
Figure 2: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Clinical Trials by Phase of Development, 2018
Figure 3: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Clinical Trials by Status, 2018
Figure 4: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Clinical Trials by Type, 2018
Figure 5: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Clinical Trials Split by Region, 2000-2018
Figure 6: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Clinical Trials by Type of Economy, 2018
Figure 7: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Enrolment by Phase, 2018
Figure 8: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Enrolment by Trial Type, 2018
Figure 9: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Enrolment by Recruitment Status, 2018
Figure 10: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Clinical Trials by Sponsor Type, 2018
Figure 11: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Enrolment by Type of Sponsors
Figure 12: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Enrolment by Leading Sponsors
Table 1: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Clinical Trials by Sponsor Type, 2018
Table 2: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Clinical Trials by Economy Type, 2018
Table 3: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Clinical Trials by Region, 2018
Table 4: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company